Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
WTAP pseudogene 1 (WTAPP1) is a human gene classified as a pseudogene and functions predominantly as a long noncoding RNA (lncRNA)[3][4][6]. Unlike protein-coding genes, WTAPP1 does not produce a functional protein but can act as a regulatory molecule at the RNA level. Studies indicate it exerts its function as a molecular decoy, particularly in endothelial progenitor cells, and is involved in the regulation of cell migration and invasion in certain cancers, including non-small cell lung cancer, possibly through interactions with other noncoding RNAs[3][4][6]. WTAPP1 is not considered a direct therapeutic target such as a receptor, enzyme, or transporter, and no known drugs or biomarkers are associated with it. However, its regulatory roles in cancer suggest it may be of interest for further research in oncology.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on WTAP pseudogene 1 (WTAPP1).